Last reviewed · How we verify

XP — Competitive Intelligence Brief

XP (XP) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: anesthetic gas. Area: Anesthesiology.

marketed anesthetic gas Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

XP (XP) — Epidemiological and Clinical Research Information Network. Xenon gas is used as an anesthetic for its sedative and amnestic properties.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
XP TARGET XP Epidemiological and Clinical Research Information Network marketed anesthetic gas
N2O exposure N2O exposure Maisonneuve-Rosemont Hospital marketed Inhalational anesthetic gas NMDA receptor (non-competitive antagonist); GABA receptors; opioid receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (anesthetic gas class)

  1. Epidemiological and Clinical Research Information Network · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). XP — Competitive Intelligence Brief. https://druglandscape.com/ci/xp. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: